Osteosarcoma cells appear to reuse this programme: exogenous BDNF enhances clonogenicity, mitigates chemotherapy-induced apoptosis and promotes a spindle-shaped, vimentin-positive phenotype, features that collectively align with heightened metastatic risk (37, 38). Here, BDNF is linked to osteosarcoma.